Ticker

BioLargo's newly formed subsidiary, BioLargo CPG, will bring to consumers the authentic, independently safety-tested CupriDyne® technology under its own brand following the marketing success of the original Pooph products that generated more than $125 million in pet-care sales while under license from BioLargo. WESTMINSTER, CA / ACCESS Newswire / July 13, 2026 / BioLargo, Inc. (OTCQX:BLGO) today announced that it is…

BLEST Renews Air Quality Compliance Work at Five Air Force Bases Across New Mexico and Arizona WESTMINSTER, CA / ACCESS Newswire / July 1, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator and engineering services solution provider, today announced that its engineering subsidiary, BioLargo Engineering, Science & Technologies (BLEST), has received contract renewals totaling more than $1.4…

BioLargo, Inc. (BLGO) Shareholder/Analyst Call Transcript

Agreement Extends Clyra's International Reach Through One of the Region's Premier Healthcare Distributors WESTMINSTER, CA / ACCESS Newswire / May 5, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator, today announced that its subsidiary Clyra Medical Technologies, Inc. has entered into an exclusive distribution agreement with Al- Hikma FZCO, headquartered in Dubai, United Arab Emirates, to…

WESTMINSTER, CA / ACCESS Newswire / May 4, 2026 / BioLargo Equipment Solutions & Technologies, Inc. ("BioLargo Equipment"), a subsidiary of BioLargo, Inc. (OTCQX:BLGO), an environmental engineering company developing and commercializing sustainable technologies, today announced it has signed into a memorandum of understanding (MOU) with Aquatech to advance the integration and commercialization of BioLargo's…